• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

    2/14/22 4:32:31 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SEAS alert in real time by email
    SC 13G/A 1 seaworld_13gam2dec312021.htm SC 13G/A

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*



    SeaWorld Entertainment, Inc.

     
    (Name of Issuer)
     
    Common Stock, par value $0.01 per share
     
    (Title of Class of Securities)

     

    81282V100

     
    (CUSIP Number)

     

     

    December 31, 2021
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    o Rule 13d-1(b)

    x Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     
     

     

     

    CUSIP No.  81282V100  SCHEDULE 13G  

     

             
    1

    NAME OF REPORTING PERSONS

     

    Melvin Capital Management LP

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) o

    (b) o

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, USA

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    5,320,000*

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    5,320,000*

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    5,320,000*

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    o
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.9%

    12

    TYPE OF REPORTING PERSON

     

    IA

    *See Item 4 for additional information.

     


     
     

     

    CUSIP No.  81282V100  SCHEDULE 13G  

     

             
    1

    NAME OF REPORTING PERSONS

     

    Melvin Capital Master Fund Ltd

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) o

    (b) o

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    4,338,861*

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    4,338,861*

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,338,861*

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    o
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.6%

    12

    TYPE OF REPORTING PERSON

     

    CO

    *See Item 4 for additional information.

     

     

     
     

     

     

     

    CUSIP No. 81282V100  SCHEDULE 13G  

     

    Item 1.   (a) Name of Issuer

    SeaWorld Entertainment, Inc. (the “Issuer”)

     

    Item 1.   (b) Address of Issuer’s Principal Executive Offices

    6240 Sea Harbor Drive, Orlando, Florida 32821

     

    Item 2.   (a, b, c) Names of Person Filing, Address of Principal Business Office, Citizenship:

    This report on Schedule 13G is being filed by Melvin Capital Management LP, a Delaware limited partnership (the “Firm”). The address for the Firm is: 535 Madison Avenue, 22nd Floor, New York, NY 10022 and Melvin Capital Master Fund Ltd, a Cayman Islands exempted company (“Melvin Master”). The address for Melvin Master is: 535 Madison Avenue, 22nd Floor, New York, NY 10022.

      

    Item 2.   (d) Title of Class of Securities

    Common Stock, par value $0.01 per share (the “Common Stock”)

     

    Item 2.   (e) CUSIP No.:

    81282V100

     

    Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person filing is a:

     

    (a)   ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

    (b)   ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

    (c)   ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

    (d)   ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

    (e)   ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

    (f)    ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

    (g)   ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

    (h)   ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i)    ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

    (j)    ☐ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

    (k)   ☐ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: _______________

     

     

     

     
     

     

     

    CUSIP No. 81282V100  SCHEDULE 13G  

     

     

    Item 4. Ownership

    Information with respect to the Firm’s ownership of securities of the issuer is incorporated by reference to items (5) - (9) and (11) of the respective cover page of the Firm.

     

    As reported in the cover pages to this report, the ownership information with respect to the Firm is as follows:

     

     
      (a) Amount Beneficially Owned: 5,320,000*
      (b) Percent of Class: 6.9%*
      (c) Number of Shares as to which such person has:  
      (i) Sole power to vote or to direct the vote: 0  
      (ii) Shared power to vote or to direct the vote: 5,320,000*
      (iii) Sole power to dispose or to direct the disposition of: 0  
      (iv) Shared power to dispose or to direct the disposition of: 5,320,000*

     

    As reported in the cover pages to this report, the ownership information with respect to Melvin Master is as follows:

     

     
      (a) Amount Beneficially Owned: 4,338,861*
      (b) Percent of Class: 5.6%*
      (c) Number of Shares as to which such person has:  
      (i) Sole power to vote or to direct the vote: 0  
      (ii) Shared power to vote or to direct the vote: 4,338,861*
      (iii) Sole power to dispose or to direct the disposition of: 0  
      (iv) Shared power to dispose or to direct the disposition of: 4,338,861*

     

    The Firm is the investment manager to Melvin Master, Melvin Capital Onshore LP, a Delaware limited partnership (“Melvin Onshore”), and one or more managed accounts (the “Managed Accounts” and together with Melvin Master and Melvin Onshore, the “Melvin Funds and Accounts”). As of December 31, 2021, the Firm may be deemed to beneficially own an aggregate of 5,320,000 shares of Common Stock. The number of shares reported above consists of (i) 4,009,061 shares of Common Stock and call options to purchase up to 329,800 shares of Common Stock held by Melvin Master, (ii) 218,784 shares of Common Stock and call options to purchase up to 18,200 shares of Common Stock held by Melvin Onshore; and (iii) 692,155 shares of Common Stock and call options to purchase up to 52,000 shares of Common Stock held by the Managed Accounts. The Firm, as the investment manager to the Melvin Funds and Accounts, may be deemed to beneficially own these securities. Gabriel Plotkin is the managing member of the general partner of the Firm and exercises investment discretion with respect to these securities. Ownership percentages are based on 77,272,923 shares of Common Stock reported as issued and outstanding in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 15, 2021.

     

     
     

    Item 5. Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

    Not Applicable.

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not Applicable.

    Item 8. Identification and Classification of Members of the Group

    Not Applicable.

    Item 9. Notice of Dissolution of Group 

    Not Applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     
     

     

     

    CUSIP No. 81282V100  SCHEDULE 13G  

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2022

     

     

    Melvin Capital Management LP

     

    By: /s/ Robert R. Rasamny

    Robert R. Rasamny, Chief Compliance Officer

     

     

    Melvin Capital Master Fund Ltd

     

    By: /s/ Robert R. Rasamny

    Robert R. Rasamny, Chief Compliance Officer

     

    Get the next $SEAS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SEAS

    DatePrice TargetRatingAnalyst
    12/14/2023$60.00 → $57.00Overweight → Equal-Weight
    Morgan Stanley
    11/1/2023$67.00 → $57.00Neutral
    JP Morgan
    7/24/2023$75.00 → $66.00Buy
    Goldman
    5/31/2023$75.00Buy
    Goldman
    5/25/2023Sector Weight
    KeyBanc Capital Markets
    4/20/2023$70.00Overweight
    Morgan Stanley
    7/13/2022Overweight → Sector Weight
    KeyBanc Capital Markets
    4/26/2022$92.00Buy
    Rosenblatt
    More analyst ratings

    $SEAS
    SEC Filings

    View All

    SeaWorld Entertainment Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - United Parks & Resorts Inc. (0001564902) (Filer)

    2/13/24 4:16:14 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits (Amendment)

    8-K/A - SeaWorld Entertainment, Inc. (0001564902) (Filer)

    1/29/24 6:30:11 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

    1/26/24 4:15:14 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SEAS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Lipman Nathaniel was granted 1,687 shares (SEC Form 4)

    4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

    1/4/24 4:46:38 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Lipman Nathaniel

    3 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

    1/4/24 4:42:26 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Hill Path Capital Partners Co-Investment S Lp was granted 1,902 shares (SEC Form 4)

    4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

    1/3/24 4:51:05 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SEAS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SeaWorld Entertainment downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded SeaWorld Entertainment from Overweight to Equal-Weight and set a new price target of $57.00 from $60.00 previously

    12/14/23 7:48:37 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    JP Morgan resumed coverage on SeaWorld Entertainment with a new price target

    JP Morgan resumed coverage of SeaWorld Entertainment with a rating of Neutral and set a new price target of $57.00 from $67.00 previously

    11/1/23 6:19:32 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Goldman reiterated coverage on SeaWorld Entertainment with a new price target

    Goldman reiterated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $66.00 from $75.00 previously

    7/24/23 10:10:47 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SEAS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SeaWorld San Antonio Reveals Plans for the ALL-NEW Rescue Jr. Hub, a Kid-Friendly World of Discovery Packed with Interactive Play, Immersive Attractions and a One-Of-A-Kind Water Elements - Opening Spring 2025

    2025 Annual Passes are now available with the best benefits ever, including Aquatica for free, free parking, free guest tickets, in-park discounts and exclusive animal experiences; 2025 Annual Pass Members will also be the first to experience Rescue Jr. DOWNLOAD HIGH-RES IMAGES HERE  SAN ANTONIO, Sept. 30, 2024 /PRNewswire/ -- SeaWorld San Antonio today unveiled its plans for an ALL-NEW friendly world of discovery, the Rescue Jr. hub, set to open Spring 2025. This immersive, hands-on adventure zone will transport young guests into the heart of SeaWorld's animal rescue efforts, where they'll tackle immersive rides, conquer towering climbing structures, splash through vibrant water features a

    9/30/24 9:00:00 AM ET
    $PRKS
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Get Ready for Jaw-Dropping Adventures as SeaWorld's Ultimate Shark Experience Returns for 2024

    SeaWorld's week-long Ultimate Shark Experience celebrates sharks in its parks with once-in-a-lifetime fin-credible opportunities for guests of all ages, all while supporting shark conservation DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., July 2, 2024 /PRNewswire/ -- SeaWorld is thrilled to unveil the return of its highly anticipated Ultimate Shark Experience ticket, available for purchase starting today. This special ticket provides guests with an exclusive opportunity to fully immerse themselves in a day filled with exciting and educational shark-focused activities. From goin

    7/2/24 8:00:00 AM ET
    $PRKS
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld and Coca-Cola Say Cheers to 60 Years with New Celebration Sundays Featuring Exclusive Merchandise Giveaways for Pass Members and Complimentary Beverage Sampling for All Guests

    Coca-Cola Celebration Sundays at SeaWorld start Sunday, June 16th and continue the third Sunday of each month for the rest of the year ORLANDO, Fla., June 13, 2024 /PRNewswire/ -- Coca-Cola is toasting SeaWorld's 60th anniversary by partnering with the parks to host "Celebration Sundays," featuring free beverage sampling for all guests and exclusive, limited-edition co-branded merchandise giveaways for pass members, while supplies last. The events kick-off on Sunday, June 16 and will continue on the third Sunday of each month through the end of the year. Each month's merchandise giveaway will be a new collectible item that will be announced prior to that month's event. June's giveaway is a 2

    6/13/24 8:00:00 AM ET
    $PRKS
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SEAS
    Leadership Updates

    Live Leadership Updates

    View All

    SeaWorld Launches 60th Anniversary Celebrations and Unveils "There's So Much More to Sea"

    Guests are invited to take advantage of limited time promotions on tickets and passes to join the celebrations, which kick off on March 21 with in-park parties and continue with thrilling new rides, shows and experiences coming this summer DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., Feb. 5, 2024 /PRNewswire/ -- SeaWorld is turning 60 this year, and to celebrate, the world-class parks are throwing a party and marking the occasion throughout the year with all-new themed rides and attractions, exciting new presentations and shows, and plenty of other exclusive ticket and experience offers, plus limited-edition food and beverage items, merchandise and collectibles that will be announced in the

    2/5/24 8:00:00 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld to Open Exciting One-Of-A-Kind Marine Life Themed Rides and Experiences for the Whole Family in Every Park in 2024

    Become a 2024 Pass Member and be the first to experience the new attractions before they open to the public; 2024 passes on sale now DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., Sept. 28, 2023 /PRNewswire/ -- SeaWorld is thrilled to announce it will open one-of-a-kind marine life themed rides and attractions in every SeaWorld park in Spring 2024.  Guests to the award-winning parks in Orlando, San Antonio, and San Diego can look forward to epic journeys and experiences for the whole family that will leave them breathless, drenched, and utterly mesmerized.  Attractions include "Penguin Trek" at SeaWorld Orlando, an all-new family friendly coaster for guests 42-77 inches in height that will transp

    9/28/23 9:00:00 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld Entertainment, Inc. Announces the Retirement of Michelle ("Chelle") Adams

    ORLANDO, Fla., July 3, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced that Chelle Adams, Chief Transformation Officer of SeaWorld Entertainment, Inc., intends to retire from SeaWorld in order to pursue personal opportunities effective August 4th, 2023. Ms. Adams will be available to the company over the coming months to ensure a smooth transition.  Marc Swanson, Chief Executive Officer of SeaWorld Entertainment, Inc. said, "On behalf of the entire Company, we want to thank Chelle for her contributions to the Company and wish her well." Chelle Adams said, "I appreciate the opportunity to have been part of the SeaW

    7/3/23 4:50:00 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SEAS
    Financials

    Live finance-specific insights

    View All

    SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2023 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

    ORLANDO, Fla., Feb. 8, 2024 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its fourth quarter and fiscal 2023 financial results before the market opens on Wednesday, February 28, 2024. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, February 28, 2024, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com or www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on February 28, 20

    2/8/24 4:30:00 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEAWORLD ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

    ORLANDO, Fla., Oct. 11, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its third quarter financial results before the market opens on Wednesday, November 8, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, November 8, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on November 8, 2023, under the "Events & Presentations" tab of www.S

    10/11/23 6:30:00 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld Entertainment, Inc. Reports Second Quarter and First Six Months 2023 Results

    ORLANDO, Fla., Aug. 8, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today reported its financial results for the second quarter and first six months of fiscal year 2023. Second Quarter 2023 Highlights Attendance was 6.1 million guests, a decrease of approximately 0.1 million guests from the second quarter of 2022.Total revenue was $496.0 million, a decrease of $8.8 million or 1.7% from the second quarter of 2022.Net income was $87.1 million, a decrease of $29.6 million or 25.3% from the second quarter of 2022.Adjusted EBITDA[1] was $224.2 million, a decrease of $10.2 million or 4.4% from the second quarter of 2022.Total revenu

    8/8/23 6:30:00 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SEAS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SeaWorld Entertainment Inc.

    SC 13G - United Parks & Resorts Inc. (0001564902) (Subject)

    2/13/24 1:09:05 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

    SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

    2/14/23 10:41:02 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13D/A filed by SeaWorld Entertainment Inc. (Amendment)

    SC 13D/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

    11/14/22 4:02:56 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care